Citation

Pedrotti Moreira F, Borges CJ, Wiener CD, da Silva PM, Portela LV, Lara DR, da Silva RA, de Mattos Souza LD, Jansen K, Oses JP. Psychiatry Res. 2018; 262: 500-504.

Copyright

(Copyright © 2018, Elsevier Publishing)

DOI

10.1016/j.psychres.2017.09.033

PMID

28942954

Abstract

Major depressive disorders (MDD) and suicide are significant public health concerns. Recent studies have been demonstrated that alterations in Brain Derived Neurotrophic Factor (BDNF) can be associated with this psychiatric disorders, MDD and suicide. Thus, the aim of this study was to evaluate differences in serum levels in individuals with MDD and with or without suicide attempt (SA), from a population-based sample. This was a paired cross-sectional study nested in a population-based study. The psychopathology screen was performed with the Mini-International Neuropsychiatric Interview (MINI). The total population of the sample consisted of 147 subjects distributed in three groups: 49 healthy controls, 49 subjects with MDD and 49 subjects with MDD and SA (MDD + SA). The BDNF serum levels were significantly reduced in subjects with MDD and MDD + SA compared to the healthy controls. However, there were no significant differences between the MDD and MDD + SA groups with respect to BDNF serum levels. These results suggest that SA did not interfere in the serum levels of BDNF, indicating that this neurotrophin may be related to the diagnosis of MDD and not to suicide attempt.

Language: en

Keywords

Humans; Cross-Sectional Studies; Adult; Female; Male; Depression; Young Adult; Suicide, Attempted; Suicide attempt; BDNF; Brain-Derived Neurotrophic Factor; Biomarker; Depressive Disorder, Major